Sputum Flow Cytometry With TCPP Labeling for Early Lung Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current lung cancer screening methods, such as LDCT, suffer from high false positive rates and invasive follow-up procedures, while sputum cytology has poor sensitivity and is subject to human bias, necessitating a more accurate and non-invasive test for early-stage lung cancer detection.
Innovation Solution
A flow cytometric method using tetra(4-carboxyphenyl) porphyrin (TCPP) labeling and automated gating to analyze sputum samples, combined with machine learning, to distinguish between cancerous and non-cancerous cells, eliminating debris and squamous epithelial cells, and incorporating cell lineage markers for accurate classification.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If LDCT screening is used for lung cancer detection, then sensitivity is improved (93.8% detection rate), but false positive rate increases (73.4% specificity) leading to unnecessary invasive procedures
Solution Approach 1:
The patent segments the diagnostic process into multiple independent assays: a first assay using TCPP fluorescence to detect cancer-associated porphyrin accumulation, and a second assay using cell lineage markers to identify specific cell types. This multi-stage segmentation allows progressive filtering of false positives while maintaining sensitivity, as each assay provides independent diagnostic information that can be combined for more accurate classification.
Solution Approach 2:
The patent introduces TCPP (tetra (4-carboxyphenyl) porphyrin) as an intermediary substance that accumulates in cancer cells through enhanced porphyrin metabolism. This intermediary serves as a chemical marker that mediates between the cancerous tissue and the detection system, providing a fluorescent signal that distinguishes cancer cells from normal cells without requiring direct observation or invasive procedures.
2Ease of operation
If sputum cytology is used for lung cancer detection, then the test is non-invasive and cost-effective, but sensitivity is poor (66% average) and subject to human bias
Solution Approach 1:
The patent replaces the manual mechanical system of pathologist slide review with an automated flow cytometry system. The flow cytometer mechanically sorts and analyzes thousands of cells based on their physical and chemical properties, including TCPP fluorescence intensity and cell lineage marker expression. This substitution eliminates human subjectivity and bias while dramatically increasing the number of cells that can be analyzed, thereby improving sensitivity from 66% to potentially much higher levels.
Solution Approach 2:
The patent changes the detection parameters from traditional morphological assessment to fluorescent signal intensity measurement. By measuring the intensity of TCPP fluorescence and the expression levels of cell lineage markers, the system quantifies cancer-related changes in a way that is more sensitive and objective than visual inspection. This parameter change allows detection of subtle differences in porphyrin accumulation that would be imperceptible to the human eye.
3Measurement precision
If flow cytometry with TCPP labeling is used, then detection accuracy is improved, but device complexity and cost increase
Solution Approach 1:
The patent leverages the multi-functionality of flow cytometry to achieve high detection accuracy without proportionally increasing complexity. The same flow cytometer can perform multiple functions: counting total cells, measuring TCPP fluorescence intensity, detecting cell lineage markers, and identifying cell types based on light scatter properties. By consolidating these functions into a single instrument rather than using multiple separate devices, the patent improves detection accuracy while limiting the increase in device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves 82% sensitivity and 88% specificity in distinguishing lung cancer from non-cancer, reducing unnecessary procedures and improving early detection accuracy.
Implementation Method 1
A flow cytometric method using tetra(4-carboxyphenyl) porphyrin (TCPP) labeling and automated gating to analyze sputum samples
Data Source
AI summary
A system and method for analyzing a sputum sample from a subject suspected of having lung cancer comprising obtaining a plurality of cells from the sputum sample from the subject, marking the plurality of cells with i) a plurality of cell lineage specific marker compositions, ii) a cell viability composition and iii) a tetra (4-carboxyphenyl) porphyrin (TCPP) composition; analyzing with the flow cytometer the plurality of cells marked with i-iii to obtain a subpopulation selected for cell size from the plurality of cells based upon an automatically selected bead size exclusion gate; from the cell size selected subpopulation, selecting a viable singlet population of cells using an automated non-debris gate and an automated singlets gate; from the viable singlet population of cells, obtaining flow cytometer values based upon the plurality of cell lineage specific marker compositions, the viability marker and the TCPP marker; applying a trained classifier to meta data from the subject and the flow cytometric values obtained; and generating, based upon the application of the trained classifier, a classification for the sputum sample wherein the classification is selected from a plurality of classification options comprising cancer and non-cancer.